701 Activating CD73 on B cells as a target for immunotherapy of COVID-19 and viral associated cancers: clinical activity in human papilloma virus positive (HPV) head and neck squamous cell cancers (HNSCC)

• Igor Puzanov,
• Richard Miller,
• Jason Luke,
• Jeffrey Sosman,
• Thomas Marron,
• Brett Hughes,
• Abhishek Tripathi,
• Mehrdad Mobasher,
• Craig Hill,
• Shenshen Hu,
• Suresh Mahabhashyam,
• Kristen Marrone,
• Jaime Merchan,
• James Janc,
• Jenny Rudnick

Affiliations

Igor Puzanov

Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA

Richard Miller

2Corvus Pharmaceuticals Inc, Burlingame, CA, USA

Jason Luke

1University of Iowa, Iowa City, IA, USA

Jeffrey Sosman

Aff341 grid.16753.360000000122993507Robert Lurie Comprehensive Cancer Center of Northwestern University Chicago IL USA

Thomas Marron

3Icahn School of Medicine at Mount Sinai, New York, NY, USA

Brett Hughes

Cancer Care Services, Royal Brisbane and Women`s Hospital, Herston, Queensland, Australia

Abhishek Tripathi

Hematology Oncology, University of Oklahoma Stephenson Cancer Center, Oklahoma City, Oklahoma, USA

Mehrdad Mobasher

2Corvus Pharmaceuticals Inc, Burlingame, CA, USA

Craig Hill

2Corvus Pharmaceuticals Inc, Burlingame, CA, USA

Shenshen Hu

2Corvus Pharmaceuticals Inc, Burlingame, CA, USA

Suresh Mahabhashyam

2Corvus Pharmaceuticals Inc, Burlingame, CA, USA

Kristen Marrone

Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA

Jaime Merchan

9University of Miami, Miami, FL, USA

James Janc

9Corvus Pharmaceuticals Inc, Burlingame, CA, United States

Jenny Rudnick

9Corvus Pharmaceuticals Inc, Burlingame, CA, United States